APLT Applied Therapeutics Gross Profit Rate

Official company branding of Applied Therapeutics, Inc. (APLT)

Applied Therapeutics develops drugs for the treatment of rare pathologies, relying on the high cost of orphan drugs to cover R&D expenses. The company implements "green chemistry" methods and utilizes production outsourcing to reduce its environmental footprint. The change in gross profit margin demonstrates the operational resilience of the business, with the indicator value standing at 59.60.

Applied Therapeutics, Inc. (APLT): Gross Margin from 07/04/2022 to 02/16/2026

Analytical breakdowns and data insights for company Applied Therapeutics (APLT)

- market value and analyst target forecast:
Basic company analysis:Applied Therapeutics Inc. APLT
Manufactured product of Applied Therapeutics Inc.

Applied Therapeutics focuses on bringing innovative drugs for the treatment of rare metabolic disorders to market, creating long-term value through regulatory approvals. This metric measures the share of profit after deducting direct production costs, allowing the investor to assess operational efficiency and the pricing power of products via the adjusted gross margin.